Quality-of-life results of double-blind, placebo-controlled trial of mesalamine in patients with Crohn's disease
- 1 May 1995
- journal article
- clinical trial
- Published by Springer Science and Business Media LLC in Digestive Diseases and Sciences
- Vol. 40 (5), 931-935
- https://doi.org/10.1007/bf02064179
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Quality of life: A valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel diseaseGastroenterology, 1994
- Mesalamine capsules for the treatment of active Crohn's disease: Results of a 16-week trialGastroenterology, 1993
- Epidemiology of Inflammatory Bowel DiseaseMedical Clinics of North America, 1990
- Oral 5-ASA Versus Prednisone in Short Term Treatment of Crohn's Disease: A Multicentre Controlled TrialCanadian Journal of Gastroenterology, 1990
- Health-related quality of life in inflammatory bowel diseaseDigestive Diseases and Sciences, 1989
- A new measure of health status for clinical trials in inflammatory bowel diseaseGastroenterology, 1989
- Responsiveness and validity in health status measurement: A clarificationJournal of Clinical Epidemiology, 1989
- Quality of Life in Patients with Inflammatory Bowel DiseaseJournal of Clinical Gastroenterology, 1988
- Measuring change over time: Assessing the usefulness of evaluative instrumentsJournal of Chronic Diseases, 1987
- Analysis of Categorical Data by Linear ModelsBiometrics, 1969